Klemann, C; Esquivel, M; Magerus-Chatinet, A; Lorenz, MR; Fuchs, I; Neveux, N; Castelle, M; Rohr, J; da Cunha, CB; Ebinger, M; Kobbe, R; Kremens, B; Kollert, F; Gambineri, E; Lehmberg, K; Seidel, MG; Siepermann, K; Voelker, T; Schuster, V; Goldacker, S; Schwarz, K; Speckmann, C; Picard, C; Fischer, A; Rieux-Laucat, F; Ehl, S; Rensing-Ehl, A; Neven, B.
Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.
Haematologica. 2017; 102(2):e52-e56-e52-e56
Doi: 10.3324/haematol.2016.153411
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG